161 related articles for article (PubMed ID: 32642122)
1. Frequency of
Champagnac A; Bringuier PP; Barritault M; Isaac S; Watkin E; Forest F; Maury JM; Girard N; Brevet M
J Thorac Dis; 2020 May; 12(5):2172-2178. PubMed ID: 32642122
[TBL] [Abstract][Full Text] [Related]
2. Incidence and PD-L1 Expression of
Xu Z; Li H; Dong Y; Cheng P; Luo F; Fu S; Gao M; Kong L; Che N
Onco Targets Ther; 2020; 13():6245-6253. PubMed ID: 32669854
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal-Epithelial Transition Exon 14 Skipping Mutation and Amplification in 5,008 Patients With Lung Cancer.
Song Y; Li G; Ju K; Ran W; Zhao H; Liu X; Hou M; He Y; Chen Y; Zang G; Xing X
Front Oncol; 2021; 11():755031. PubMed ID: 34660325
[TBL] [Abstract][Full Text] [Related]
4. Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.
Pruis MA; Geurts-Giele WRR; von der TJH; Meijssen IC; Dinjens WNM; Aerts JGJV; Dingemans AMC; Lolkema MP; Paats MS; Dubbink HJ
Lung Cancer; 2020 Feb; 140():46-54. PubMed ID: 31862577
[TBL] [Abstract][Full Text] [Related]
5. Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
Kim EK; Kim KA; Lee CY; Kim S; Chang S; Cho BC; Shim HS
Clin Lung Cancer; 2019 Jan; 20(1):e123-e132. PubMed ID: 30391211
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.
Descarpentries C; Leprêtre F; Escande F; Kherrouche Z; Figeac M; Sebda S; Baldacci S; Grégoire V; Jamme P; Copin MC; Tulasne D; Cortot AB
J Thorac Oncol; 2018 Dec; 13(12):1873-1883. PubMed ID: 30195702
[TBL] [Abstract][Full Text] [Related]
7. MET Exon 14 Skipping in Non-Small Cell Lung Cancer.
Heist RS; Shim HS; Gingipally S; Mino-Kenudson M; Le L; Gainor JF; Zheng Z; Aryee M; Xia J; Jia P; Jin H; Zhao Z; Pao W; Engelman JA; Iafrate AJ
Oncologist; 2016 Apr; 21(4):481-6. PubMed ID: 27022036
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel MET Exon 14 Skipping Variants in Non-Small Cell Lung Cancer Patients: A Prototype Workflow Involving in Silico Prediction and RT-PCR.
Das R; Jakubowski MA; Spildener J; Cheng YW
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230737
[TBL] [Abstract][Full Text] [Related]
9. DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer.
Davies KD; Lomboy A; Lawrence CA; Yourshaw M; Bocsi GT; Camidge DR; Aisner DL
J Thorac Oncol; 2019 Apr; 14(4):737-741. PubMed ID: 30639620
[TBL] [Abstract][Full Text] [Related]
10. An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples.
Bironzo P; Pepe F; Russo G; Pisapia P; Gragnano G; Aquino G; Bessi S; Buglioni S; Bartoccini F; Ferrero G; Bresciani MA; Francia di Celle P; Sibona F; Giusti A; Movilia A; Farioli RM; Santoro A; Salemi D; Scarpino S; Galafate D; Tommasi S; Lacalamita R; Seminati D; Sajjadi E; Novello S; Pagni F; Troncone G; Malapelle U
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832117
[TBL] [Abstract][Full Text] [Related]
11. Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach.
Sui JSY; Finn SP; Gray SG
Methods Mol Biol; 2021; 2279():145-155. PubMed ID: 33683691
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations.
Schrock AB; Frampton GM; Suh J; Chalmers ZR; Rosenzweig M; Erlich RL; Halmos B; Goldman J; Forde P; Leuenberger K; Peled N; Kalemkerian GP; Ross JS; Stephens PJ; Miller VA; Ali SM; Ou SH
J Thorac Oncol; 2016 Sep; 11(9):1493-502. PubMed ID: 27343443
[TBL] [Abstract][Full Text] [Related]
14. The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC.
Liu SY; Gou LY; Li AN; Lou NN; Gao HF; Su J; Yang JJ; Zhang XC; Shao Y; Dong ZY; Zhou Q; Zhong WZ; Wu YL
J Thorac Oncol; 2016 Sep; 11(9):1503-10. PubMed ID: 27257131
[TBL] [Abstract][Full Text] [Related]
15. Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline
Jiao Y; Fang C; Yang Y; Shao L; Huang Y; Sun Q; Dong Y
Onco Targets Ther; 2021; 14():2417-2421. PubMed ID: 33854337
[No Abstract] [Full Text] [Related]
16. MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung.
Saffroy R; Fallet V; Girard N; Mazieres J; Sibilot DM; Lantuejoul S; Rouquette I; Thivolet-Bejui F; Vieira T; Antoine M; Cadranel J; Lemoine A; Wislez M
Oncotarget; 2017 Jun; 8(26):42428-42437. PubMed ID: 28418914
[TBL] [Abstract][Full Text] [Related]
17. Non-small-cell lung cancer: how to manage
Blaquier JB; Recondo G
Drugs Context; 2022; 11():. PubMed ID: 35855460
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Cohen D; Hondelink LM; Solleveld-Westerink N; Uljee SM; Ruano D; Cleton-Jansen AM; von der Thüsen JH; Ramai SRS; Postmus PE; Graadt van Roggen JF; Hoppe BPC; Clahsen PC; Maas KW; Ahsmann EJM; Ten Heuvel A; Smedts F; van Rossem RN; van Wezel T
J Thorac Oncol; 2020 Jun; 15(6):1000-1014. PubMed ID: 32014610
[TBL] [Abstract][Full Text] [Related]
19. MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapy.
Wong SK; Alex D; Bosdet I; Hughesman C; Karsan A; Yip S; Ho C
Lung Cancer; 2021 Apr; 154():142-145. PubMed ID: 33667719
[TBL] [Abstract][Full Text] [Related]
20. MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.
Awad MM; Oxnard GR; Jackman DM; Savukoski DO; Hall D; Shivdasani P; Heng JC; Dahlberg SE; Jänne PA; Verma S; Christensen J; Hammerman PS; Sholl LM
J Clin Oncol; 2016 Mar; 34(7):721-30. PubMed ID: 26729443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
